Plaintiff, a resident of Oakland, Alameda County, California, filed a child birth defect lawsuit (Case Number: R615761042 – Superior Court Of State Of California, County of Alameda) against pharmaceutical conglomerate GlaxoSmithKline (GSK) alleging that her son’s birth defects were caused by his mother ingesting Zofran (Ondansetron) during the first trimester of her pregnancy. In the lawsuit, which is the third in a series of similar complaints filed against GSK, the plaintiff’s son is referred to as J.S.
To view the original complaint, click on the button below.
Birth Defects Named In Complaint As Caused By Zofran
In the two lawsuits prior to this one, plaintiffs alleged that Zofran was the proximate cause of 9 different birth defects. You can read about these defects in this article titled: “9 Birth Defects Named In Zofran Lawsuits“. In this California case, claimant gave birth to her son who was diagnosed with supraventricular tachycardia, (“SVT”). The lawsuit alleges that plaintiff took Zofran early in her first trimester and alleges that her son’s SVT was caused by Zofran. The complaint continues to state that there was no history of SVT in her family and that she did not know at the time of taking Zofran that it could cause such defects. The complaint stated that had she known, she would not have taken Zofran.
Pain And Suffering In Zofran Lawsuit
Plaintiff’s complaint states that her son’s condition required the prescription of Digoxin to help with SVT symptoms, which were:
- shortness of breath
- rapid breathing
- shallow breathing
The complaint continued making a demand for compensation against the defendant for medical expenses, and the pain and suffering that her son endured as a result of the child birth defect. Plaintiff also claimed for her own sustained severe emotional distress and suffering in having to live through the experience and care for her son.
What Is Supraventricular Tachycardia?
Supraventricular Tachycardia is a condition where the heart rate beats at a very rapid rate, which is beyond normal. The condition is abbreviated as SVT or PSVT and usually shows a heart beat of 100 beats per minute, well above the normal rate of 60-90 beats per minute. This results in heart muscles not being able to relax between beats, which has the knock on effect of the chambers not being able to fill properly to supply the remainder of the body with oxygenated blood.
PSVT is one of the most common arrhythmia in infants and children.